PortfoliosLab logo

Ascendis Pharma A/S (ASND)

Equity · Currency in USD · Last updated Mar 30, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Ascendis Pharma A/S in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $58,728 for a total return of roughly 487.28%. All prices are adjusted for splits and dividends.


100.00%200.00%300.00%400.00%500.00%600.00%NovemberDecember2023FebruaryMarch
487.28%
101.17%
ASND (Ascendis Pharma A/S)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ASND

Ascendis Pharma A/S

Return

Ascendis Pharma A/S had a return of -9.45% year-to-date (YTD) and -0.69% in the last 12 months. Over the past 10 years, Ascendis Pharma A/S had an annualized return of 24.23%, outperforming the S&P 500 benchmark which had an annualized return of 8.95%.


PeriodReturnBenchmark
1 month-2.47%1.46%
Year-To-Date-9.45%4.90%
6 months10.43%10.43%
1 year-0.69%-11.97%
5 years (annualized)11.10%8.82%
10 years (annualized)24.23%8.95%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20231.60%-10.47%
202215.28%11.37%7.01%-0.76%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ascendis Pharma A/S Sharpe ratio is -0.01. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20NovemberDecember2023FebruaryMarch
-0.01
-0.51
ASND (Ascendis Pharma A/S)
Benchmark (^GSPC)

Dividend History


Ascendis Pharma A/S doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2023FebruaryMarch
-39.49%
-16.03%
ASND (Ascendis Pharma A/S)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Ascendis Pharma A/S. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ascendis Pharma A/S is 57.28%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-57.28%Dec 15, 2020354May 11, 2022
-42.92%Jul 17, 2015225Jun 7, 2016165Feb 1, 2017390
-33.15%Feb 21, 202017Mar 16, 202046May 20, 202063
-30.77%Jun 4, 201990Oct 9, 201954Dec 26, 2019144
-27.69%Aug 28, 201882Dec 24, 201846Mar 4, 2019128
-24.67%Mar 3, 201770Jun 12, 201772Sep 22, 2017142
-24.09%Apr 24, 201533Jun 10, 201524Jul 15, 201557
-17.6%Mar 14, 201925Apr 17, 201931Jun 3, 201956
-13.95%Mar 13, 201818Apr 6, 201835May 25, 201853
-13.92%Jun 24, 202013Jul 13, 202058Oct 2, 202071

Volatility Chart

Current Ascendis Pharma A/S volatility is 30.03%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2023FebruaryMarch
30.03%
16.43%
ASND (Ascendis Pharma A/S)
Benchmark (^GSPC)